Amazon (AMZN) Offering Possible 50.66% Return Over the Next 17 Calendar Days

Amazon's most recent trend suggests a bullish bias. One trading opportunity on Amazon is a Bull Put Spread using a strike $3380.00 short put and a strike $3340.00 long put offers a potential 50.66% return on risk over the next 17 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $3380.00 by expiration. The full premium credit of $13.45 would be kept by the premium seller. The risk of $26.55 would be incurred if the stock dropped below the $3340.00 long put strike price.

The 5-day moving average is moving up which suggests that the short-term momentum for Amazon is bullish and the probability of a rise in share price is higher if the stock starts trending.

The 20-day moving average is moving up which suggests that the medium-term momentum for Amazon is bullish.

The RSI indicator is at 70.13 level which suggests that the stock is neither overbought nor oversold at this time.

To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here

LATEST NEWS for Amazon

Dow Jones Futures Rise With Apple, Tesla Stock Splits, TikTok Deal Delay Hits Microsoft, Walmart; Two Key Stock Market Rally Charts
Mon, 31 Aug 2020 09:52:40 +0000
Dow Jones futures rose amid Apple and Tesla stock splits. Microsoft and Walmart fell on TikTok deal delays. The stock market rally is flashing warning signs.

EU's Dombrovskis calls for international taxation of digital services
Mon, 31 Aug 2020 08:32:54 +0000
The European Union needs to tax companies that generate its revenues with digital services as the money is needed to fund infrastructure and social programmes in the future, European Commission Vice President Valdis Dombrovskis said on Monday. “We need to address the digital taxation, and we need to do it preferably internationally because especially the digital economy is quite globalised,” Dombrovskis, who also has temporary responsibility for trade, said at Austria's Alpbach economic forum, which he joined online. “With more digital economy it becomes also more of a challenge for our tax revenues to finance our infrastructure and social programmes,” he said.

Amazon Orders 1,800 Electric Vans From Mercedes-Benz As Street Stays Bullish
Mon, 31 Aug 2020 06:13:07 +0000
Amazon announced that it has ordered more than 1,800 electric vehicles (EVs) from Mercedes-Benz for its European van delivery fleet this year.The move to switch to EVs is part of Amazon’s (AMZN) commitment to reduce emissions from the transportation sector, and run net zero carbon businesses by 2040 – a decade ahead of the Paris Agreement goal of 2050. The order represents the largest electric vehicle commitment for Mercedes-Benz vans to date.More than 1,200 EVs in the order will consist of the newest electric commercial van available at Mercedes-Benz – the eSprinter, a larger model than the manufacturer’s first zero-emission vehicle, the eVito. The eSprinter includes safety features such as electrical parking brake, active brake assist, reverse camera, and blind spot assist. The remaining 600 vehicles will be comprised of the manufacturer’s midsize electric van, the eVito, to give delivery service partners operating in geographies that require a smaller-format vehicle access to a zero-emissions delivery option.The EVs from this order are scheduled to start making deliveries to customers in 2020, helping to save thousands of metric tons of carbon, Amazon added.Mercedes-Benz announced it has also joined The Climate Pledge, which calls on signatories to be net zero carbon across their businesses by 2040. The Climate Pledge was co-founded by Amazon and Global Optimism.“Amazon is adding 1,800 electric delivery vehicles from Mercedes-Benz as part of our journey to build the most sustainable transportation fleet in the world, and we will be moving fast to get these vans on the road this year,” said Amazon CEO Jeff Bezos. “We need continued innovation and partnership from auto manufacturers like Mercedes-Benz to decarbonize the transportation sector and tackle the climate crisis.”Mercedes-Benz said that by the end of this year, its vehicle portfolio will comprise five fully electric models and more than 20 plug-in hybrids.The commitments come as demand for EVs is slated to grow in the long-term even as COVID-19 has currently disrupted the electric vehicle market and the whole automotive industry as well. Several countries are encouraging individuals and businesses to transition to EVs to bring down toxic emissions and ensure sustainability.Cairn Energy Research Advisors estimate that global sales of electric cars will grow 36% in 2021 and will cross 3 million for the first time. The trend has also incentivized other carmakers to tap the growth potential. Earlier this month, General Motors (GM) and EVgo announced a collaboration to add more than 2,700 fast chargers in the US over the next five years, in a move set to help boost widespread use of EVs.Shares in Amazon have been on a steady winning streak jumping a stellar 84% so far this year, with the $3,725.59 average analyst price target implying almost 10% upside potential is lying ahead in the coming 12 months.In a bullish note, Loop Capital Markets analyst Anthony Chukumba earlier this month hiked AMZN’s price target to $3,775 from $2,900 and maintained a Buy rating on the stock.Chukumba is confident that the “pull-forward” of consumer e-commerce adoption in groceries, health and personal care induced by the coronavirus pandemic will boost growth for the company "well beyond" COVID-19. The analyst also increased his target operating margin estimate for US first-party retail sales to 8% from 7%.Overall, AMZN scores 38 Buy ratings from analysts versus 1 Hold rating adding up to Strong Buy consensus. (See Amazon stock analysis on TipRanks).Related News: GM, EVgo Team Up To Add 2,700 EV Fast Chargers; CS Says Buy Stock Now GM To Release Electric Truck Next Year With 20 More EVs By 2023 Microsoft Plans To Become Carbon Neutral By 2030 More recent articles from Smarter Analyst: * MGM To Cut 18,000 Furloughed US Employees – Report * Transport Canada Completes Simulator Flight Tests Of Boeing’s 737 MAX * Herbalife To Pay $123M To Settle China Bribery Case; Street Says Buy * Nio To Sell 75M Shares; Stock Drops 7%

Demand for Online Doctors Creates $39 Billion Titan in Japan
Mon, 31 Aug 2020 00:44:52 +0000
(Bloomberg) — Two decades ago, Itaru Tanimura ended a 12-year run at McKinsey & Co. to lead M3 Inc., an online provider of medical information and services backed by entertainment giant Sony Corp.What followed was a flurry of acquisitions that turned the Tokyo-based company into a $39 billion global behemoth. M3 now has about 40 subsidiaries and affiliates, including MDLinx Inc. in the U.S. and Britain’s Ltd.M3 helps pharmaceutical companies, doctors and their patients access information online over its platforms, removing the need for in-person visits — something that proved important in the time of Covid-19. Its shares have almost doubled this year, surging the most of any company in the Nikkei 225 Stock Average and taking the fortune of Tanimura to $1.2 billion, according to the Bloomberg Billionaires Index.“Online doctor capabilities are in the spotlight with Covid, as people are staying home,” Jefferies Japan Ltd. analyst Hiroko Sato said in an interview. “It’s really a theme stock.”Inquiries SkyrocketThe shares climbed 1.2% by 9:44 a.m. in Tokyo Monday.A rush by smaller pharma companies to digitalize marketing materials after the coronavirus outbreak helped boost sales, with inquiries skyrocketing. M3’s operating profit climbed 26% in the quarter ended in June, beating the highest analyst estimate.The company’s name stands for “the three Ms of Medicine, Media and Metamorphosis,” and its goal is to change medicine by “making full use of the power of the Internet,” according to its website.Its acquisition spree started in 2002, when M3 bought the Japanese unit of U.S. medical portal site WebMD. MDLinx was acquired in 2006 and in 2011. M3, which gets about three-quarters of its revenue from Japan, also has units in China, India and France. One of its U.S. subsidiaries was selected to take part in Moderna Inc.’s Covid-19 vaccine study.Tanimura, 55, is president and holds a 2.9% stake in M3. Sony owns about a third of the company. M3 declined to comment for this story, while Sony didn’t respond to phone calls and an email seeking comment.Tech WealthThe pandemic has produced vast wealth gains among both tech and pharma titans. Inc.’s Jeff Bezos has amassed more than anyone else, with his fortune hitting $200 billion, while Tencent Holdings Ltd.’s Pony Ma and Jiang Rensheng, the chairman of vaccine maker Chongqing Zhifei Biological Products Co., have added more than $11 billion each.While M3 said in its earnings report that Covid-19 disrupted some of its business, it always has Sony to lean on. The entertainment giant unveiled a $100 million relief fund to help tackle the outbreak in April and funneled some of that cash toward M3.“Sony and M3 will be able to bring unprecedented ideas to the medical community,” Tanimura said at the time. “Our first priority will be the rapid development of contributive measures to the fight against Covid-19.”(Adds stock move in fifth paragraph)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.

3 High-Growth Stocks That Are Just Getting Started
Sun, 30 Aug 2020 14:20:00 +0000
Here's why Slack Technologies (NYSE: WORK), (NASDAQ: JD), and Farfetch (NYSE: FTCH) could be future multibaggers. It's basically replacing email at the workplace, and with more people working from home during the pandemic, Slack has really come into its own this year. Revenue has grown exponentially over the last few years, but Slack is still a relatively small company with a lot of potential to gain the business of more customers across different industries.

Related Posts


MarketTamer is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of MarketTamer are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.

This company makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity’s compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.

The content on any of MarketTamer websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The educational training program and software services are provided to improve financial understanding.

The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.